Table 2. Plasmids used in this study.
Name | Description | Resistance† | Reference |
pBAD33 | p15A ori | Cm | [40] |
pCB192-YY | pCB192 but no EcoRI site in 3′ of lacZ | Amp | [38], This study |
pCVD442 | vector for allelic exchange | Amp | [37] |
pET-RctB | pET28b rctB | Km | [7] |
pGZ119EH | ColD ori | Cm | [41] |
pSM843 | pET28b parB2 | Km | [15] |
pSM922 | pBAD33 parB2 | Cm | Sarah McLeod, This study |
pWKS30 | pSC101 ori | Amp | [42] |
pXX705 | F ori | Amp | [43] |
pYB141 | pXX705 parS2-A | Amp | This study |
pYB190 | pCRII | Km | [16] |
pYB193 | pBAD33 parS2-A | Cm | This study |
pYB199 | pKD4 MCS* | Amp, Km | This study |
pYB216 | pBAD33 parS2X | Cm | This study |
pYB217 | pXX705 parS2X | Amp | [15] |
pYB264 | pYB199 rctA oriCII rctB | Amp, Km | This study |
pYB273 | pGZ119EH parB2 | Cm | This study |
pYB276 | pYB199 oriCII rctB | Amp, Km | This study |
pYB285 | pGZ119EH rctB | Cm | [7] |
pYB289 | oriCII rctB | Km | [7] |
pYB292 | rctA oriCII rctB | Km | This study |
pYB294 | pBAD33 rctB | Cm | This study |
pYB355 | pET28b rctB[ΔC159] | Km | This study |
pYB379 | pYB199 rctA (parS2-B::parS2X) oriCII rctB | Amp, Km | This study |
pYB403 | pYB199 parB2 parA2 rctA oriCII rctB | Amp, Km | This study |
pYB404 | parB2 parA2 rctA oriCII rctB | Amp, Km | This study |
pYB405 | pCRII oriCII | Km | This study |
pYB406 | pCRII rctA | Km | This study |
pYB407 | pCRII rctA (parS2-B::parS2X) | Km | This study |
pYB432 | pCVD442-based allelic exchange plasmid to construct ΔrctA | Amp | This study |
pYB445 | pCVD442-based allelic exchange plasmid to construct parS2-B::parS2X | Amp | This study |
pYB447 | pSC101 parS2-A | Amp | This study |
pYB448 | pSC101 parS2X | Amp | This study |
pYB451 | pSC101 parS2-A parS2-A | Amp | This study |
pYB452 | pCB192-YY PparAB2-rctA lacZ | Amp | This study |
pYB453 | pCB192-YY PparAB2-rctA (parS2-B::parS2X) lacZ | Amp | This study |
pYB558 | rctA (parS2-B::parS2X) oriCII rctB | Km | This study |
*MCS; multi cloning site.
†Resistance; Amp, ampicillin; Cm, chloramphenicol; Km, kanamycin.